Alto Neuroscience, Inc. (ANRO) — Net Asset Quality Index
Alto Neuroscience, Inc. (ANRO) has a Net Asset Quality Index of 81.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $184.69 Million minus total liabilities of $33.55 Million yields net assets of $151.14 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Alto Neuroscience, Inc. (ANRO) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Alto Neuroscience, Inc. Net Asset Quality Index Over Time (2021–2025)
This chart shows how Alto Neuroscience, Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 81.8%, representing net assets of $151.14 Million against total assets of $184.69 Million USD. Explore Alto Neuroscience, Inc. operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Alto Neuroscience, Inc. (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Alto Neuroscience, Inc. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ANRO company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.8% | $151.14 Million | $184.69 Million | $33.55 Million | ▼ -3.5 pp |
| 2024 | 85.3% | $151.46 Million | $177.54 Million | $26.08 Million | ▲ +168.0 pp |
| 2023 | -82.7% | $-71.67 Million | $86.63 Million | $158.30 Million | ▼ -7.2 pp |
| 2022 | -75.5% | $-38.41 Million | $50.85 Million | $89.26 Million | ▼ -32.2 pp |
| 2021 | -43.3% | $-12.48 Million | $28.79 Million | $41.27 Million | — |